Biosensors and Terumo target lucrative Japanese market
This article was originally published in Clinica
Executive Summary
Biosensors International and Terumo have formed a deal that they believe could set them on a path to become a major supplier of drug-eluting stent (DES) systems in Japan and Asia in the next few years.